HOME >> MEDICINE >> NEWS
Common heart failure drugs can be safely used at higher, more effective doses, study says

Commonly prescribed heart failure drugs known as ACE inhibitors are often given at lower doses than recommended by leading cardiology associations. A new study of the ACE inhibitor lisinopril written by a researcher at San Francisco VA Medical Center and University of California, San Francisco shows that the vast majority of heart failure patients can safely tolerate higher doses, which have been proven to reduce death and hospitalizations significantly.

The research is published in the latest issue of the Archives of Internal Medicine, written by Barry Massie, MD, SFVAMC chief of cardiology and UCSF professor of medicine, on behalf of the group of researchers who conducted the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial.

Although a number of different ACE inhibitors have been proven in clinical trials to reduce mortality in heart failure patients, a majority of physicians who prescribe these drugs use lower doses than were shown to be effective in clinical trials, Massie said. These doctors have been concerned that the drugs might dangerously lower patients' blood pressure, impair kidney function, or greatly elevate potassium levels, he said.

The new study showed that for a great majority of patients, going from a low dose to a high dose did not cause these severe side effects. "As a rule, giving patients the full recommended dose of ACE inhibitors should cause relatively few problems, if given properly and according to previous studies will reduce deaths and hospitalizations," Massie said.

Nearly five million Americans currently have congestive heart failure, and nearly 50,000 die of the disease each year, according to the American Heart Association. Roughly 70 percent of heart failure patients are prescribed an ACE inhibitor, said Massie.

In this study, Massie and his colleagues performed a secondary analysis of data from the ATLAS trial, a randomized clinical trial of lisinopril, one of the most popular ACE i
'"/>

Contact: Kevin Boyd
kboyd@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
31-Jan-2001


Page: 1 2 3

Related medicine news :

1. Common anesthetics appear safe for developing fetal brain
2. Common schizophrenia symptoms often overlooked by physicians, according to expert panel
3. Common antidepressants lower effects of tamoxifen in many women
4. Common antidepressant may affect youths bone development
5. Common epilepsy treatment to be used for bulimia nervosa
6. Mouth sores: Common complaints of students
7. Common drug, given promptly, reduces incidence of post-traumatic stress disorder, small study finds
8. New Commonwealth Fund analysis compares candidtes health care reform proposals
9. Common heart surgery potentially dangerous
10. Common treatment for cancer pain stimulates breast tumor growth in mice
11. Common diabetes drug causes arteries to spasm, endangering heart

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... CHICAGO (PRWEB) , ... July 02, 2020 , ... ... technology intended for the treatment of autoimmune diseases. Its lead indication is ... for vitiligo at this time. , While vitiligo is equally prevalent ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... Outstanding Safety Professional of the Year Award to Eric Simmons of Temecula, California. ... than 250 nominations. Simmons, who holds a master’s degree in occupational safety and ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... dental offices for non-emergency work. In conjunction with the American Dental Association and ... dental practices in mid-May. , Due to safety concerns, the announcement sparked ...
(Date:7/1/2020)... ... July 01, 2020 , ... ABSTRAX, an industry leader in ... new terpene infused product line including custom rolling papers, cones, flat wraps, ... profiles and flavors worldwide. , “We’ve made it easier than ever for brands ...
(Date:7/1/2020)... ... July 01, 2020 , ... The Society to ... of Medicine at the University of Massachusetts Medical School- Baystate and Ann Gaffey, ... the SIDM Board of Directors. Dr. Salvador and Ms. Gaffey’s service began in ...
Breaking Medicine News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... The team at The ... their completely redesigned website. The new site offers a multitude of user enhancements and ... downloadable information available with easy to navigate menus which will allow patients to find ...
(Date:7/10/2020)... ... July 10, 2020 , ... ... of business and technology for the pharmaceutical industry throughout North America has ... the highest quality pharmaceutical products. QC Corner will feature content ...
(Date:7/7/2020)... Wis. (PRWEB) , ... July 07, 2020 , ... Nonprofit ... Fund for Global PH Research Award at its first ever virtual research town hall ... along with clinical experts will showcase the latest research in the area of pulmonary ...
Breaking Medicine Technology:
Cached News: